Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2025 09:56 ET | Source: GHO Capital

Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners

Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid...
December 10, 2024 16:05 ET | Source: Avid Bioservices, Inc

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024

TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
November 07, 2024 11:27 ET | Source: Wohl & Fruchter LLP

CDMO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Avid Bioservices to GHO Capital Partners and Ampersand Capital Partners

We are investigating the fairness of the proposed sale of Avid Bioservices for $12.50 per share in cash to GHO Capital and Ampersand Capital.
September 12, 2024 16:05 ET | Source: Avid Bioservices, Inc

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
September 09, 2024 16:05 ET | Source: Avid Bioservices, Inc

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...
July 01, 2024 07:00 ET | Source: Avid Bioservices, Inc

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
May 23, 2024 08:05 ET | Source: Avid Bioservices, Inc

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
May 07, 2024 16:05 ET | Source: Avid Bioservices, Inc

Avid Bioservices to Participate at Upcoming Investor Conferences

TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
April 03, 2024 04:45 ET | Source: Johnson Fistel, LLP

Investigation into Avid Bioservices, Inc. Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations - What Shareholders Need to Know!

Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Avid Bioservices, Inc.
March 28, 2024 13:19 ET | Source: Block & Leviton LLP

SHAREHOLDER ALERT: Avid Bioservices Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Avid Bioservices, Inc. (NASDAQ: CDMO) for potential securities law violations. Investors who have lost money in their...